Commercially Available Prostaglandin Analogs for the Reduction of Intraocular Pressure: Similarities and Differences
- 30 November 2008
- journal article
- review article
- Published by Elsevier BV in Survey of Ophthalmology
- Vol. 53 (6), S69-S84
- https://doi.org/10.1016/j.survophthal.2008.08.012
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Update on the Mechanism of Action of Topical Prostaglandins for Intraocular Pressure ReductionSurvey of Ophthalmology, 2008
- Topical WIN55212-2 Alleviates Intraocular Hypertension in Rats Through a CB1 Receptor Mediated Mechanism of ActionJournal of Ocular Pharmacology and Therapeutics, 2008
- Prostamides (prostaglandin‐ethanolamides) and their pharmacologyBritish Journal of Pharmacology, 2008
- Prostaglandins Increase Trabecular Meshwork Outflow Facility in Cultured Human Anterior SegmentsAmerican Journal of Ophthalmology, 2008
- The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and actionBritish Journal of Pharmacology, 2007
- Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline irisBritish Journal of Pharmacology, 2007
- Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patientsOphthalmology, 2005
- Human Ciliary Muscle Cell Responses to FP-Class Prostaglandin Analogs: Phosphoinositide Hydrolysis, Intracellular Ca2+ Mobilization and MAP Kinase ActivationJournal of Ocular Pharmacology and Therapeutics, 2003
- Endocannabinoid hydrolasesProstaglandins & Other Lipid Mediators, 2002
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001